Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application
about
Histone acetyltransferases: challenges in targeting bi-substrate enzymesLiver cancer stem cell markers: Progression and therapeutic implicationsCancer Stem Cells in the ThyroidAldehyde dehydrogenase 1A1 in stem cells and cancerAldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsAldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's diseaseAldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neuronsNonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylasesThe mechanism of discrimination between oxidized and reduced coenzyme in the aldehyde dehydrogenase domain of Aldh1l1Structural basis of substrate selectivity of Δ1-pyrroline-5-carboxylate dehydrogenase (ALDH4A1): Semialdehyde chain lengthStructures of Proline Utilization A Reveal the Fold and Functions of the Aldehyde Dehydrogenase Superfamily Domain of Unknown FunctionThe Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaAldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cellsCrystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acidDevelopment of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1The cysteine proteomeA transposable element insertion confers xenobiotic resistance in DrosophilaCurrent approaches for the discovery of drugs that deter substance and drug abuse.Modulation of Ethanol-Metabolizing Enzymes by Developmental Lead Exposure: Effects in Voluntary Ethanol ConsumptionCombination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysisDark Hydrazone Fluorescence Labeling Agents Enable Imaging of Cellular Aldehydic Load.Effect of various diets on the expression of phase-I drug-metabolizing enzymes in livers of miceAldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsBenomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.Oral epithelial stem cells - implications in normal development and cancer metastasis.Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors.NEK2 mediates ALDH1A1-dependent drug resistance in multiple myelomaCharacterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.Next generation of ALDH substrates and their potential to study maturational lineage biology in stem and progenitor cellsA personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variantRelation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder.Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humansPathogen-associated molecular patterns activate expression of genes involved in cell proliferation, immunity and detoxification in the amebocyte-producing organ of the snail Biomphalaria glabrata.Structural Basis of Substrate Recognition by Aldehyde Dehydrogenase 7A1.Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma.A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity.
P2860
Q26745642-F715F88E-1944-4D89-904E-A1515910F8A9Q26751026-E39D7ED7-45F7-4E6E-92D6-58043A6F925FQ26765947-F6ADEB33-95B6-43E5-A3DE-271193C28181Q26771185-B9563128-2432-4DAE-8003-35587D7512B1Q26786476-F41AD343-6E48-409A-9407-73BE79A86EB6Q26850502-EDB84A11-9A2F-4C2F-A4D8-8786FF64EE43Q26852122-CAD6313D-DCC0-44AC-86AE-89A93E0BA8D9Q27024524-662E596C-FCE5-4D3E-90E3-A3D157AE9C2BQ27675774-48459925-2773-45C1-BD38-E1B52E88C02EQ27679462-E8F3C75F-EEB6-4DD9-9126-9E5BD9D28973Q27728132-BFFC9FBD-710E-4C25-B113-0E7D6DC17471Q28071619-E9F90194-21C1-461B-B1F4-FDC7BFC1768BQ28078884-0E8787A5-0611-415F-B755-191F54038211Q28115266-84493740-EBA0-41CE-B2CD-AD3686EAD13FQ28117499-29E41695-CA7F-4D06-B388-404DC3679272Q28395817-72D1158F-2871-4E6B-BC34-965D2E74F875Q28541894-ED669F2A-7B46-4B61-B23A-952D3947DEA4Q28973615-4A22FDAD-B1B2-421C-8B81-28CB47D14DA1Q33715211-C5956482-BAE5-4944-A8F4-5E231F20B4C6Q33778101-DCB7AD77-2473-4691-ADF9-7D87B29A8153Q33804523-6BA029C4-FEB3-44B7-AE46-1A7982F82DEBQ33887825-8FDFF221-FEC1-4242-879D-16A46D60187FQ33894107-BB0C48A8-3D03-4545-A940-E9F86C249CB3Q34026132-F16C315C-7CAD-4426-A88A-676B8AD911DBQ34065897-F728C791-A8DE-4183-BC71-30B87904F561Q34147649-57FF55B1-8B59-4D11-A619-67394806BBA7Q34395219-0177FA58-7425-4EEE-84E2-3A324199860AQ34647295-9885A3D6-C763-4AE8-909B-B1F620D9A99EQ35067960-81B43A0B-32BF-4303-A9D6-55FDCF7CCEDEQ35130660-4C4090F9-37CB-48BA-AA88-4ADF800BFC9EQ35177969-B80FF507-F26C-4FB9-A3FF-88E874F23E20Q35274173-D024BC11-04FB-42FC-BFA1-E0A5697474FEQ35619842-BC1F9656-22C8-4F95-86C3-686862B130E0Q35643960-3F96121F-2A18-489B-B2D4-81F2BCA6A7ADQ35846201-9E40279D-C222-42A7-B466-4CB8AD9DB0A4Q35848242-766F0C65-8AB2-440A-A824-DD4D7A289C82Q36045705-6ACD0234-B08B-4253-A26E-562DA724B01BQ36159646-5565D1C3-DB1E-4C43-B2D1-22D60D8B709DQ36172612-4B61ADAA-5C3C-435B-AD15-E3A36BF0F3DFQ36262477-30E9B0D1-3C04-417D-B3E5-56D8724E02EB
P2860
Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@ast
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@en
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@nl
type
label
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@ast
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@en
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@nl
prefLabel
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@ast
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@en
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@nl
P2093
P2860
P3181
P356
P1476
Aldehyde dehydrogenase inhibit ...... city, and clinical application
@en
P2093
David C Thompson
Dennis Petersen
Kyriacos C Nicolaou
Manuel Ellermann
Richard A Deitrich
Risto O Juvonen
Thomas D Hurley
Vindhya Koppaka
P2860
P304
P3181
P356
10.1124/PR.111.005538
P407
P577
2012-07-01T00:00:00Z